Similar articles

• High levels of aggrecan aggregate components are present in synovial fluids from human knee joints with chronic injury or osteoarthrosis.

  Ratcliffe A, Grelsamer RP, Kiernan H, Saed-Nejad F, Visco D. Ratcliffe A, et al. Acta Orthop Scand Suppl. 1995 Oct;266:111-5. Acta Orthop Scand Suppl. 1995. PMID: 8553838 No abstract available.
• Aggrecan degradation in osteoarthritis and rheumatoid arthritis.

  Lark MW, Bayne EK, Lohmander LS. Lark MW, et al. Acta Orthop Scand Suppl. 1995 Oct;266:92-7. Acta Orthop Scand Suppl. 1995. PMID: 8553869 Review. No abstract available.
• Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.

  Manicourt DH, Poilvache P, Van Egeren A, Devogelaer JP, Lenz ME, Thonar EJ. Manicourt DH, et al. Arthritis Rheum. 2000 Feb;43(2):281-8. doi: 10.1002/1529-0131(200002)43:2<281::AID-ANR7>3.0.CO;2-7. Arthritis Rheum. 2000. PMID: 10693867
• Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.

  Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T, Emery P, Poole AR, Veale DJ. Fraser A, et al. Arthritis Rheum. 2003 Nov;48(11):3085-95. doi: 10.1002/art.11331. Arthritis Rheum. 2003. PMID: 14613270
• Keratan sulfate in body fluids in joint disease.

  Thonar EJ, Masuda K, Häuselmann HJ, Uebelhart D, Lenz ME, Manicourt DH. Thonar EJ, et al. Acta Orthop Scand Suppl. 1995 Oct;266:103-6. Acta Orthop Scand Suppl. 1995. PMID: 8553836 Review. No abstract available.